Impact of Chinese criteria on potentially inappropriate medication use in China.

ABSTRACT:

Background

In 2018, China issued a set of criteria for effectively identifying and managing potentially inappropriate medication (PIM) use in older adults. However, there is currently a lack of evidence regarding the impact of these criteria on PIM use among older Chinese adults.

Methods

We used interrupted time series analysis on the prescription data of older outpatients from 59 hospitals in six major geographic regions of China to compare changes in the overall prevalence of PIM use, the prevalence of PIM use stratified by different numbers of PIMs, and the prevalence of top five PIMs (i.e. clopidogrel, estazolam, zolpidem, sliding-scale insulin, and alprazolam) from 2015 (before) to 2021 (after) the release of criteria in 2018.

Results

We included 982 605 older ou

SUBMITTER: Tian F 

PROVIDER: S-EPMC11801653 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature